UniProtKB/Swiss-Prot P51168: Variant p.Gly442Val

Amiloride-sensitive sodium channel subunit beta
Gene: SCNN1B
Feedback?

Variant information Variant position:

442 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Glycine (G) to Valine (V) at position 442 (G442V, p.Gly442Val). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from glycine (G) to medium size and hydrophobic (V) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs1799980 [ dbSNP | Ensembl ]

Sequence information Variant position:

442 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

640 The length of the canonical sequence.
Location on the sequence:

DWAHCYSDLQMSVAQRETCI G MCKESCNDTQYKMTISMADW The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         DWAHCYSDLQMSVAQRETCIGMCKESCNDTQYKMTISMADW

                              DWAYCYSHLRMSVAQRETCINMCKESCNDTQYKMTISMADW

Chimpanzee                    DWAHCYSDLQMSVAQRETCIGMCKESCNDTQYKMTISMADW

Mouse                         DWAYCYLNLQMSVTQRETCLSMCKESCNDTQYKMTISMADW

Rat                           DWAYCYLSLQMSVVQRETCLSMCKESCNDTQYKMTISMADW

Bovine                        DWAHCYSALRISLAQRETCIYACKESCNDTQYKMTISMAVW

Rabbit                        DWAPCYLALRMSEAERETCIRMCKESCNDTQYKMTISMADW

Sheep                         DWAHCYSALRISMAQRETCIYACKESCKLLGTSPPLPPCLL

Xenopus laevis                DWVPCYYSLRDSVAIRENCISLCQQPCNDTHYKMVISMADW

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 640	Amiloride-sensitive sodium channel subunit beta
Topological domain	72 – 532	Extracellular
Helix	434 – 443

Literature citations
Genetic analysis of the beta subunit of the epithelial Na+ channel in essential hypertension.
Persu A.; Barbry P.; Bassilana F.; Houot A.-M.; Mengual R.; Lazdunski M.; Corvol P.; Jeunemaitre X.;
Hypertension 32:129-137(1998)
Cited for: VARIANTS MET-434; VAL-442; SER-589; MET-594; HIS-597; CYS-624 AND GLY-632; Genetic analysis of Rwandan patients with cystic fibrosis-like symptoms: identification of novel cystic fibrosis transmembrane conductance regulator and epithelial sodium channel gene variants.
Mutesa L.; Azad A.K.; Verhaeghe C.; Segers K.; Vanbellinghen J.F.; Ngendahayo L.; Rusingiza E.K.; Mutwa P.R.; Rulisa S.; Koulischer L.; Cassiman J.J.; Cuppens H.; Bours V.;
Chest 135:1233-1242(2009)
Cited for: VARIANT BESC1 MET-348; VARIANT VAL-442;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.